Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaki Shinoda is active.

Publication


Featured researches published by Masaki Shinoda.


Tetrahedron Letters | 1986

A convenient synthesis of β-alkynylpropionic acids from β-propiolactones. Synthesis of 4,4,5,5-tetradehydro-9(O)-methano-Δ6(9α)-PGI1

Masaki Shinoda; Katsuhiko Iseki; Tomei Oguri; Yosio Hayasi; Shun-ichi Yamada; Masakatsu Shibasaki

A new prostacyclin analog, 4,4,5,5-tetradehydro-9(0)-methano-gD6(9α)-PGI, has been synthesized by utilizing the regiocontrolled cleavage of the β-propiolactone uith the dialkylaluminum acetylide.


Bioorganic & Medicinal Chemistry Letters | 2008

5-Aryl-imidazolin-2-ones as a scaffold for potent antioxidant and memory-improving activity

Kazutoshi Watanabe; Yasuhiro Morinaka; Yoshio Hayashi; Masaki Shinoda; Hiroyoshi Nishi; Nobuko Fukushima; Toshiaki Watanabe; Akira Ishibashi; Satoshi Yuki; Masahiko Tanaka

A series of 5-phenyl-substituted-N-alkyl-imidazolin-2-ones with potent radical-scavenging activity and lipid peroxidation inhibitory activity was synthesized. Many of the compounds showed memory-improving effect in animal models independent of the inhibitory activity on lipid peroxidation.


Redox Report | 2003

Synthesis of the metabolites of a free radical scavenger edaravone (MCI-186, Radicut™ )

Kazutoshi Watanabe; Masao Taniguchi; Masaki Shinoda

Abstract Two metabolites of a free radical scavenger, edaravone, were synthesized. Edaravone glucuronate was synthesized by glycosylation of a glucuronic acid precursor using silver (I) trifluoromethane-sulfonate with edaravone. Edaravone sulfate was synthesized by sulfonylation of edaravone using a sulfur trioxide-pyridine complex. The two synthesized metabolites were identical to isolated metabolites. X-ray analysis identified edaravone glucuronate as β-O-glucuronate, although there were three possible edaravone glucuronate tautomers.


Archive | 1985

Pharmaceuticals containing prostaglandin I2

Akira Ishibashi; Daijiro Horii; Toshiji Kanayama; Katsuhiko Iseki; Masaki Shinoda; Chiyoko Ishiyama; Yosio Hayashi; Masakatsu Shibasaki; Mikiko Sodeoka; Yuji Ogawa; Toshiaki Mase


Archive | 1986

Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing SRS by employing the same

Yoshio Hayashi; Tomei Oguri; Masaki Shinoda; Kazuo Takahashi


Archive | 1990

4-IMIDAZOLINE DERIVATIVES

Yoshio Hayashi; Yasuhiro Morinaka; Masaki Shinoda; Hiroyoshi Nishi; Kazutoshi Watanabe; Nobuko Fukushima


Archive | 1988

Carboxystyrene derivatives and drugs containing them as effective ingredients

Yoshio Hayashi; Tomei Oguri; Masaki Shinoda; Kazuo Takahashi; Munehiro Hashimoto


Archive | 1986

(2-chloro-3-oxo-1-alkenyl)bicyclo(3.3.0)octane derivative

Masakatsu Shibasaki; Katsuhiko Iseki; Masaki Shinoda; Chiyoko Aoki; Yoshio Hayashi


Archive | 1986

(2-Chloro-3-oxo-1-alkenyl)bicyclo (3.3.0.) octene derivative and process for preparing the same

Masakatsu Shibasaki; Katsuhiko Iseki; Masaki Shinoda; Chiyoko Aoki; Yoshio Hayashi


Archive | 1990

4-Imidazoline derivatives and their use in preparing pharmaceutical compositions

Yoshio Hayashi; Yasuhiro Morinaka; Masaki Shinoda; Hiroyoshi Nishi; Kazutoshi Watanabe; Nobuko Fukushima

Collaboration


Dive into the Masaki Shinoda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge